We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis’ Valsartan in Government Crosshairs Again, This Time in Japan
Novartis’ Valsartan in Government Crosshairs Again, This Time in Japan
Novartis’ valsartan woes escalated Thursday as Japan followed the U.S. in filing a legal complaint against the Swiss drugmaker over its marketing practices for the blood pressure drug.